Introducing the NEW ALLSKIN | MED Medical-Grade Retinoid portfolio:
Retinoid Pigment Control Emulsions
Retinoid Texture Repair Emulsion
Exclusive to medical aesthetic skin clinics, the ALLSKIN | MED Retinoid Portfolio is scientifically formulated to elevate and enhance the management and treatment of:
Hyperpigmentation
Ageing & Photodamaged Skin
Textural Problems & Acne-Prone Skin
The ALLSKIN | MED Retinoid Portfolio is powered by RETINDUO®, the clinically proven dual pathway retinoid technology exclusive to Cantabria Labs. The portfolio combines targeted potency levels of this triple innovation with evidence-based dermatological ingredients in expert formulations developed to address these specific skin concerns and deliver1,2:
The ALLSKIN | MED Retinoid Portfolio is launching with an exclusive ALLSKIN | MED Skin Preparation Protocol gift with purchase.
Find out how to launch the ALLSKIN | MED Retinoid Portfolio in your clinic contact your Clinic Development Manager or enquire here.
ALLSKIN | MED Retinoid Pigment Control Emulsions
An innovative medical-grade approach for skin clinic patients with photodamage and hyperpigmentation, to reduce hyperpigmentation and dark spots, unify skin tone, and increase skin firmness and elasticity.
Powered by RETINDUO® Technology, at three medical-grade potency levels: 1, 2, 3 and expertly formulated with a clinically proven pigment correction system combining Tranexamic Acid and Niacinamide, to accelerate pigment reduction and support the skin’s biological processes that help reduce melanin production.
Reoxderm® patented antioxidant barrier technology, and a moisturising repair system hydrate and protect the skin barrier, helping to reduce inflammation and enhance the skin’s tolerance to the retinoid activity.
Results after only 27 days of once-daily use1:
Reported more radiant and luminous skin
Reported firmer skin
Reported improved skin elasticity
High levels of skin comfort and tolerability
Recommended by experts
“By combining ALLKSIN | MED’s advanced retinoid technology with tranexamic acid and niacinamide, this formulation addresses both existing pigment and the underlying drivers of hyperpigmentation, without compromising skin integrity.“
ALLSKIN | MED Retinoid Texture Repair Emulsion
An advanced lightweight medical-grade formulation particularly suitable for combination, oily and acne-prone skin. Powered by RETINDUO® technology at retinoid potency level 2, designed to improve skin texture, refine pores, regulate sebum and promote a smoother, more balanced complexion, while also helping to improve signs of ageing.
Reoxderm® patented antioxidant barrier technology, alongside an advanced moisturising and tri-peptide repair complex, protects and hydrates the skin barrier and helps balance the skin microbiome, helping reduce redness and enhance the skin’s tolerance to the retinoid activity.
Results after only 27 days of once-daily use2:
Reported improved skin texture and tone
Reported smoother skin
Reported reduced appearance of fine lines
High levels of skin comfort and tolerability
Recommended by experts
“ALLSKIN | MED’s Texture Repair Emulsion is designed for sustained daily use, progressively refining skin texture and supporting collagen remodelling without compromising the skin barrier, delivering a measurable and lasting improvement in skin clarity and uniformity.”
ALLSKIN | MED Retinoid Renewal Serums
Advanced silky, lightweight renewal serums powered by RETINDUO® technology, available in retinoid potency levels 1 and 2, designed to support epidermal renewal and longer-term dermal stimulation to improve and delay early and visible signs of ageing and a loss of skin vitality.
Enhanced with EDAFENCE® antioxidant and anti-pollution technology, supported by niacinamide, vitamin E and hydrating actives, the formula helps protect against environmental aggressors, reinforce the skin barrier and improve overall skin resilience, ensuring optimal tolerability of medical-grade retinoid use.
Recommended by experts
“ALLSKIN | MED’s Renewal Serums provide an evidence-based introduction to retinoid therapy, stimulating collagen synthesis, enhancing epidermal renewal and protecting against DNA damage, to progressively restore luminosity and improve overall skin quality with excellent tolerability.”
NEW RETINDUO® Technology x ALLSKIN | MED
ALLSKIN | MED, the advanced medical-grade skincare portfolio from Cantabria Labs, exclusively developed for skin clinics. Now features the groundbreaking NEW RETINDUO® Technology.
RETINDUO® Dual Technology – Triple Innovation
NEW RETINDUO® is Cantabria Labs’ advanced dual-retinoid technology. Developed with a unique triple innovation, it delivers a dual retinoid pathway with bioavailability optimisation:
Pure retinol in microsponges for long-lasting effect
Retinal AOX Tech-encapsulated retinal for immediate and controlled action
Optimised by bioavailability-boosting natural ingredients to optimise retinoid activity within the skin
BETTER EFFICACY. HIGHER TOLERANCE3.
Discover the ALLSKIN | MED Retinoid Portfolio
The Power of RETINDUO® – Clinical Proof3
A double blind controlled study with RETINDUO® level 2 potency in a study of 40 women following a prescriptive retinization programme over a 3-month period delivered clinically proven progressive and sustainable skin enhancement results.
After 4 weeks of gradual retinoid acclimatisation, clinical assessment showed:
Skin firmness significantly increased
Skin hydration improved
Wrinkle depth reduced
After a further 2 months of regular nighttime use, clinical assessment showed:
Skin firmness increased by 30%
Epidermal health increased by 30%
Sustained and continuous reduction in wrinkle depth
Excellent skin tolerance
Before and after images from double blind controlled study – Day 0 and Day 843
Discover the ALLSKIN | MED Retinoid Portfolio
MEDICAL AESTHETICS x Retinoids
Retinoids are Vitamin A (retinol) and its derivatives retinyl esters, retinal, and retinoic acid. They are essential for the skin’s natural biology and play a key role in maintaining skin health.
In dermatology and medical aesthetics, retinoids are considered the gold standard ingredients. Promoting skin cell renewal, collagen synthesis, and hyaluronic acid production. They have been clinically proven to help improve skin conditions that medical aesthetic clinics treat every day, including: 4-10
Visible signs of skin ageing – including wrinkles
Uneven skin tone and hyperpigmentation
Rough texture
Loss of firmness
That’s why the innovators at Cantabria Labs developed RETINDUO® to deliver dual pathway retinoid activity in a triple innovation that enhances retinoid bioavailability in the skin.
The ALLSKIN | MED Advanced Retinoid Medical-Grade Portfolio combines RETINDUO® with evidence-based dermatological ingredients, in expert skin-clinic-exclusive formulations to provide products that practitioners want to prescribe and patients love to use. Helping enhance their treatment and management of:
Hyperpigmentation
Ageing and photodamaged skin
Textural problems and acne-prone skin
Let’s Chat Retinoids x ALLSKIN | MED
To find out how the ALLSKIN | MED Advanced Retinoid Medical-Grade Portfolio can work for you and how to launch the gift with purchase promotion in-clinic, talk to our friendly and knowledgeable clinic development team.
References
1 ALLSKIN | MED Pigment Control Emulsion (Potency 2 – Medium). Tolerance and Efficacy Assessment, 20 subjects with normal to combination skin (35-60 years of age), application to face once daily for 27 days. Subjective Evaluation. CRO: AlYeDerm Clinic & Research, Spain, (2025). Data on file.
2 ALLSKIN | MED Texture Repair Emulsion. Tolerance and Efficacy Assessment, 20 subjects with normal to combination skin (35-60 years of age), application to face once daily for 27 days. Subjective Evaluation. CRO: AlYeDerm Clinic & Research, Spain, (2025). Data on file.
3 RetinDuo Potency level 2 compared to 0.5% Retinol in wrinkle amplitude and viscoelasticity. Instrumental Efficacy and Tolerance Assessment, 40 female subjects with normal to combination skin 35-60 years of age, once-daily application for 84 days. Eurofins Product Testing, Cosmetics & Personal Care Spain, S.L.U., Spain, (2025). Data on file.
4 Kligman LH, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. N Engl J Med. 1986;314(26):1636–1641.
5 Weiss JS, Ellis CN, Headington JT, Hamilton TA, Voorhees JJ. Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled study. JAMA. 1988;259(4):527–532.
6 Creidi P, Vienne MP, Ochonisky S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. Dermatology. 1998;196(4):447–452.
7 Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–348.
8 Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin: therapy, pathogenesis, and prevention. Arch Dermatol. 1997;133(10):1280–1284.
9 Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335–339.
10 Kang S, Duell EA, Fisher GJ et al. Application of Retinol to Human Skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. The Journal of Investigative Dermatology. Vol 105. No. 4. October 1995.